Advances in the treatment of neurodegenerative disorders employing nanotechnology

Annals of the New York Academy of Sciences

Volumn 1184, Issue , 2010, Pages 154-172

  Modi, Girish ^a   Pillay, Viness ^a   Choonara, Yahya E ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Alzheimer's disease; Blood brain barrier; Drug delivery; Drug targeting; Engineered nanomaterials; Multifunctional nanoparticles; Nano biotechnology; Nanoparticles; Nanoscience; Nanostructured; Nanotechnology; Neurobiology; Neuroscience; Polymers; Site specific

Indexed keywords

AMINO GROUP MODIFIED CHOLESTEROL BEARING PULLULAN; AMYLOID BETA PROTEIN; CARBON NANOTUBE; CHOLESTEROL BEARING PULLULAN; CLIOQUINOL; DNA; DOPAMINE; ENBUCRILATE; GLYCEROL NUCLEIC ACID; GOLD NANOPARTICLE; METHYL BETA CYCLODEXTRIN; MOLECULAR SCAFFOLD; NANOCAPSULE; NANOFIBER; NANOGEL; NANOLIPOSOME; NANOMICELLE; NANOPARTICLE; NANOSPHERE; NANOSUSPENSION; NANOWIRE; NEUROTROPHIC FACTOR; ORGANICALLY MODIFIED SILICA; PENICILLAMINE; PULLULAN; SILICON DIOXIDE; THIOFLAVINE; UNCLASSIFIED DRUG; VIRUS VECTOR; LIPOSOME;

ALZHEIMER DISEASE; BIOSENSOR; BLOOD BRAIN BARRIER; BRAIN DEPTH STIMULATION; CONVECTION ENHANCED DELIVERY; DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG RELEASE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; NANOCHIP; NANOROBOT; NANOTECHNOLOGY; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; REVIEW; STEM CELL TRANSPLANTATION; SURFACE PROPERTY; BRAIN DISEASE; CLASSIFICATION; CYTOSOL; METABOLISM; METHODOLOGY; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ALZHEIMER DISEASE; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN DISEASES; CYTOSOL; HUMANS; LIPOSOMES; NANOCAPSULES; NANOPARTICLES; NANOSPHERES; NANOTECHNOLOGY; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE;

EID: 77949884839     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05108.x     Document Type: Review

References (100)

1. McArthur, J.C. 2004. HIV dementia: An evolving disease. J. Neuroimmunol. 157: 3-10.
2. Flachenecker, P. 2006. Epidemiology of neuroimmunological diseases. J. Neurol. 253: 2-8.
3. Kabanov, A.V. & H.E. Gendelman. 2007. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog. Polym. Sci. 32: 1054-1082. (Pubitemid 47198293)
4. Ferri, CR, M. Prince, C. Brayne, et al. 2005. Global prevalence of dementia: A delphi consensus study. Lancet 366: 2112-2117. (Pubitemid 41797645)
5. Popovic, N. & P. Brundin. 2006. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. Int. J. Pharm. 314: 120-126.
6. Coyle, J. & P. Kershaw. 2001. Biol. Psych. 49:289.
7. Marder, K. 2004. Curr. Neurol. Neurosci. Rep. 4: 349.
8. Zandi, P.P., J.C. Anthony, A.S. Khachaturian, et al. 2004. J. Arch. Neurol. 61: 82.
9. Selkoe, D.J. 2001. Physiol. Rev. 81: 741.
10. Nash, J.M. 2001. Time 157: 85.
11. Singh, N., V. Pillay & Y.E. Choonara. 2007. Advances in the treatment of Parkinson's disease. Prog. Neurobiol. 81: 29-44.
12. Freed, C.R., P.E. Greene, R.E. Breeze, et al. 2001. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344: 710-719.
13. Kostarelos, K. & A.D. Miller. 2005. Synthetic, selfassembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors. Chem. Soc. Rev. 34: 970-994.
14. Born, P.J.A. & D. Muller-Schulte. 2006. Nanoparticles in drug delivery and environmental exposure: same size, same risks? Nanomedicine 1: 235-249.
15. Xu, Z.R, Q.H. Zeng, G.Q. Lu & A.B. Yu. 2007. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem. Eng. Sci. 61: 1027-1040.
16. Foged, C. & H.M. Nielsen. 2008. Cell-penetrating peptides for drug delivery across membrane barriers. Expert Opin. Drug Deliv. 5: 1435-11342
17. Leary, S.R, C.Y. Liu & M.L.J. Apuzzo. 2006. Toward the emergence of nanoneurosurgery: Part IIInanomedicine: Targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery. Neurosurg. 58: 1009-1026.
18. Gaur, A., A. Midha & A.L. Mbatia. 2008. Applications of nanotechnology in medical sciences. Asian J. Pharm. 2: 80-85.
19. Ma, S.H., L.A. Lepak, R.J. Hussain, et al. 2005. An endothelial and astrocyte co-culture model of the blood-brain barrier utilizing an ultra-thin, nanofabricated silicon nitride membrane. Lab Chip. 5: 74-85.
20. Miller, G. 2002. Drug targeting: breaking down barriers. Science 297: 1116-1118.
21. Calvo, P., B. Gouritin, H. Villarroya, et al. 2002. Quantification and localization of pegylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat. Eur. J. Neurosci. 15: 1317-1326.
22. Gupta, A.K., C. Berry, M. Gupta & A. Curtis. 2003. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Trans. Nanobiosci. 2: 255-261.
23. Kreuter, J. 2004. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J. Nanosci. Nanotechnol. 4: 484-488. (Pubitemid 39387399)
24. Cui, Z., R Lockman, R. Atwood, et al. 2005. Novel d-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases. Eur. J. Pharm. Biopharm. 59: 263-272. (Pubitemid 40127583)
25. Muller, R.H. & C.M. Keck. 2004. Drug delivery to the brain-realization by novel drug carriers. J. Nanosci. Nanotechnol. 4: 471-483. (Pubitemid 39402941)
26. Behan, N., C. Birkinshaw & N. Clarke. 2001. Poly nbutyl cyanoacrylate nanoparticles: a mechanistic study of polymerization and particle formation. Biomat. 22: 1335-1344. (Pubitemid 32409955)
27. Calvo, P., B. Gouritin, H. Chacun, et al. 2001. Longcirculating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm. Res. 18: 1157-1166. (Pubitemid 32900402)
28. Alyaudtin, R.N., A. Reichel, R. Lobenberg, et al. 2001. Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro. J. Drug Target. 9: 209-221. (Pubitemid 32776368)
29. Kreuter, J., R Ramge, V. Petrov, et al. 2003. Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm. Res. 20: 409-416. (Pubitemid 36288370)
30. Steiniger, S.C., J. Kreuter, A.S. Khalansky, et al. 2004. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int. J. Cancer 109: 759-767.
31. Hyuk, I.M.S., U. Jeong & Y. Xia. 2005. Polymer hollow particles with controllable holes in their surfaces. Nat. Mater. 4: 671-675.
32. Kreuter, J., R. Alyautdin, D. Kharkevich & A. Ivanov. 1995. Passage of peptides through the blood-brain barrier with collodial polymer particles (nanoparticles). Brain Res. 674: 171-174.
33. Kreuter, J. 2001. Nanoparticulate systems for brain delivery of drugs. Adv. Drug Deliv. Rev. 47: 65-81. (Pubitemid 32209233)
34. Kreuter, J., D. Shamenkov, V. Petrov, et al. 2002. Apolipoprotein- mediated transport of nanoparticlebound drugs across the blood-brain barrier. J. Drug Target. 10: 317-325. (Pubitemid 34746313)
35. Bronich, T.K., S. Bontha, L.S. Shlyakhtenko, et al. 2006. Template-assisted synthesis of nanogels from pluronicmodified poly(acrylic acid). J. Drug Targeting 14: 357-366. (Pubitemid 44203516)
36. Bontha, S., A.V. Kabanov & T.K. Bronich. 2006. Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs. J. Control. Rel. 114: 163-174. (Pubitemid 44308502)
37. Vinogradov, S.V., A.D. Zeman, E.V. Batrakova & A.V. Kabanov. 2005. Polyplex nanogel formulations for drug delivery of cytotoxic nucleoside analogs. J. Control. Rel. 107: 143-157.
38. Kumar, R.M., M. Sameti, et al. 2003. Polymeric nanoparticles for drug and gene delivery. In Encyclopedia of Nanoscience & Nanotechnology. Nalwa, H.S., Ed.: 1-19. American Scientific Publishers.
39. Friedrich, I., S. Reichl & C.C. Muller-Goymann. 2005. Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS). Int. J. Pharm. 305: 167-175. (Pubitemid 41562227)
40. Kabanov, A.V. & H.E. Gendelman. 2007. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog. Polym. Sci. 32: 1054-1082. (Pubitemid 47198293)
41. McKenzie, J.L., M.C. Waid, R. Shi & T.J. Webster. 2004. Decreased functions of astrocytes on carbon nanofiber materials. Biomat. 25: 1309-1317.
42. du Toit, L.C., V. Pillay, Y.E. Choonara, et al. 2007. Patenting of nanopharmaceuticals in drug delivery: No small issue. Recent Patents on Drug Deliv. Form. 1:.131-142.
43. Nguyen, H.K., P. Lemieux, S.V. Vinogradov et al. 2000. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 7: 126-138.
44. Harada-Shiba, M., K. Yamauchi, A. Harada, et al. 2002. Polyion complex micelles as vectors in gene therapypharmacokinetics and in vivo gene transfer. Gene Ther. 9: 407-414. (Pubitemid 34414039)
45. Oishi, M., H. Hayashi, M. Iijima & Y. Nagasaki. 2007. Endosomal release and intracellular delivery of anticancer drugs using pH-sensitive pegylated nanogels. J. Mater. Chem. 17: 3720-3725. (Pubitemid 47330703)
46. Shi, N., W. Zhang, C. Zhu, et al. 2001. Brain-specific expression of an exogenous gene after i.v. administration. Proc. Natl. Acad. Sci. USA 98: 12754-12759. (Pubitemid 33026054)
47. Voinea, M. & M. Simionescu. 2002. Designing of 'intelligent' liposomes for efficient delivery of drugs. J. Cell Mol. Med. 6: 465-474. (Pubitemid 44146431)
48. Mora, M., M.L. Sagristá, D. Trombetta, et al. 2002. Design and characterization of liposomes conta ininglongchain N-acylpes for brain delivery: penetration of liposomes incorporating GM1 into the rat brain. Pharm. Res. 19: 1430-1438. (Pubitemid 35266546)
49. Schmidt, J., J.M. Metselaar, M.H.M. Wauben, et al. 2003. Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain 126: 1895-1904. (Pubitemid 36917348)
50. Gosk, S., C. Vermehren, G. Storm & T. Moos. 2004. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion. J. Cereb. Blood Flow Metab. 24: 1193-1204. (Pubitemid 39482480)
51. Chekhonin, V.P., Y.A. Zhirkov, O.I. Gurina, et al. 2005. Pegylated immunoliposomes directed against brain astrocytes. Drug Deliv. 12: 1-6. (Pubitemid 40066254)
52. Cherney, R.A., C.S. Atwood, M.E. Xilinas, et al. 2001. Treatment with a copper-zinc chelator markedly and rigidly inhibits B-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30: 665-676.
53. Roney, C., P. Kulkarn, V. Arora, et al. 2005. Targeted nanoparticles for drug delivery through the bloodbrain barrier for Alzheimer's disease. J. Control. Rel. 108: 193-214. (Pubitemid 41608654)
54. Torchilin, V.P. 2002. Peg-based micelles as carriers of contrast agents for different imaging modalities. Adv. Drug Deliv. Rev. 54: 235-252.
55. Begley, D.J. 2004. Delivery of therapeutic agents to the central nervous system: The problems and the possibilities. Pharmacol. Ther. 104: 29-45. (Pubitemid 39410561)
56. Ritchie, C.W., A.I. Bush & C.L. Masters. 2004. Metalprotein attenuating compounds and Alzheimer's disease. Expert Opin. Invest. Drugs 13: 1585-1592.
57. Hartig, W., B. Paulke, C. Varga, et al. 2003. Electron microscopic analysis of nanoparticles delivering thioflavin-T after intrahippocampal injection in mouse: implications for targeting h-amyloid in Alzheimer's disease. Neurosci. Lett. 338: 174-176. (Pubitemid 36140163)
58. Dong, J., C. Atwood, V. Anderson, et al. 2003. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: raman microscopic evidence. Biochem. 42: 2768-2773. (Pubitemid 36331519)
59. Liu, C.Y., M.L. Apuzzo & D.A. Tirrell. 2003. Engineering of the extracellular matrix: working toward neural stem cell programming and neuro restorationconcept and progress report. Neurosurg. 52: 1154-1165.
60. Lovell, M., J. Robertson, W. Teesadale, et al. 1998. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158: 47-52.
61. Mandel, S.A., T. Amit, M. Machluf & M.B.H. Youdim. 2007. Nanoparticles: A step forward for iron chelation in the brain. Future Neurol. 2:265-269.
62. Kogan, M.J., N.G. Bastus, R.D. Grillo-Bosch, et al. 2006. Nanoparticle-mediated local and remote manipulation of protein aggregation. Nano Lett. 6: 110-115.
63. Subramani, K., A. Khraisat & A. George. 2008. SelfAssembly of proteins and peptides and their applications in bionanotechnology. Curr. Nanosci. 4: 201-207.
64. Stupp, S.I. 2007. Nanotechnology offers hope for treating spinal cord injuries, diabetes and Parkinson's disease. Nanowerk, http://www.nanowerk.com/ news/newsid=1816.php. Accessed on 2.20.2009.
65. Yan, H., S.H. Park, G. Finkelstein, et al. 2003. DNAtemplated self-assembly of protein arrays and highly conductive nanowires. Science 301: 1882-1884.
66. Ke, Y., S. Lindsay, Y. Chang, et al. 2008. Self-assembled water-soluble nucleic acid probe tiles for label-free RNA hybridization assays. Science 319: 180-183.
67. Seeman, N.C. 2005. From genes to machines: DNA nanomechanical devices. Trends Biochem. Sci. 30: 119-125.
68. Niemeyer, C.M. 2000. Self-assembled nanostructures based on DNA: Towards the development of nanobiotechnology. Curr. Opin. Chem. Biol. 4: 609-618.
69. Liu, H., J. Gao, S.R. Lynch, et al. 2003. A four-base paired genetic helix with expanded size. Science 302: 868-871.
70. Yang, Y.W., S. Zhang, E.O. McCullum & J.C. Chaput. 2007. Experimental evidence that GNA and TNA were not sequential polymers in the prebiotic evolution of RNA. J. Mol. Evol. 65: 289-295.
71. Zhang, R.S., E.O. McCullum & J.C. Chaput. 2008. Synthesis of two mirror image 4-helix junctions derived from glycerol nucleic acid. J. Am. Chem. Soc. 130: 5846-5847.
72. Chaput, J. 2008. GNA: DNA chemical cousin is a nanotechnology building block. Sci. Blog. Sci. 2, http://www.scientificblogging.com/news'releases/. Accessed on 2.20.2009.
73. Simpkins J.W. & N. Bodor. 1994. Brain-targeted delivery of dopamine using a redox-based chemical delivery system. Adv. Drug Deliv. Rev. 14: 243-249.
74. Fiandaca, M.S., J.R. Forsayeth, P.J. Dickinson & K.S. Bankiewicz. 2008. Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurother. 5: 123-127.
75. Neuwelt, E.A. 2004. Mechanisms of disease: the bloodbrain barrier. Neurosurg. 54:131-140.
76. Nowakowski, G.S. & T.E. Witzig. 2006. Radioimmunotherapy for B-cell non-Hodgkin lymphoma. Clin. Adv. Hematol. Oncol 4: 225-231.
77. Bobo, R.H., D.W. Laske, A. Akbasak, et al. 1994. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad. Sci. USA 91: 2076-2080.
78. Krauze, M.T., J. Forsayeth, J.W. Park & K.S. Bankiewicz. 2006. Real-time imaging and quantification of brain delivery of liposomes. Pharm. Res. 23: 2493-2504.
79. Lidar, Z., Y. Mardor & T. Jonas, et al. 2004. Convectionenhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: A phase I/II clinical study. J. Neurosurg. 100: 472-479.
80. Kioi, M., S.R. Husain, D. Croteau, et al. 2006. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy. Technol. Cancer Res. Treat. 5: 239-250.
81. Anderson, W.F. 1998. Human gene therapy. Nature 392: 25-30.
82. Davis, S.S. 1997. Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Trends Biotechnol 15: 217-224.
83. Luo, D. & W.M. Saltzman. 2000. Synthetic DNA delivery systems. Nat. Biotechnol. 18: 33-37.
84. Klejbor, I., E.K. Stachowiak, D.J. Bharali, et al. 2007. ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology. J. Neurosci. Meth. 165: 230-243.
85. Jain, K.K. 2005. The role of nanobiotechnology in drug discovery. Drug Discov. Today 10: 1435-1442.
86. Yurek, D. 2007. Nanoparticle gene therapy for Parkinson's disease. Nanotechwire.com. http://nanotechwire.com/news.asp?nid=4393&ntid= 183&pg=8. Accessed on 2.20.2009.
87. Kaplitt, M.G. & M.J. During. 2008. Gene therapy study shows safety and statistically significant improvement in Parkinson's disease. Biomed. http://www. bio-medicine.org/biology-news/Gene-therapy-studyshows-safety-and- statistically-significant-improvement-in-Parkinsons-disease-5440-1/. Accessed on 2.20.2009.
88. Nisbet, D.R., K.E. Crompton, M.K. Home, et al. 2007. Neural tissue engineering of the CNS using hydrogels. J. Biomed. Mat. Res. Part B: App. Biomat. 1: 251-263.
89. Lindvall, O. & P. Hagell. 2002. Role of cell therapy in Parkinson's disease. Neurosurg. Focus. 13: e2.
90. Parati, E.A., A. Bez, D. Ponti, et al. 2003. Neural stem cells: Biological features and therapeutic potential in Parkinson's disease. J. Neurosurg. Sci. 47: 8-17.
91. Kim, J.H., J.M. Auerbach, J.A. Rodríguez-Gómez, et al. 2002. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418: 50-56.
92. Barberi, T., P. Klivenyi, N.Y. Calingasan, et al. 2003. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat. Biotech. 21: 1200.
93. Woo, S.H. 2004. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 303: 1669-1674.
94. Silva, G.A., C. Czeisler, K.L. Niece, et al. 2004. Selective differentiation of neural progenitor cells by highepitope density nanofibers. Science 303: 1352-1355.
95. Englund, U., A. Bjorklund, K. Wictorin, et al. 2002. Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc. Natl. Acad. Sci. USA 99: 17089-17094.
96. Li, J., H.T. Ng & H. Chen. 2008. Protein nanotechnology protocols, instrumentation, and applications. In Methods in Molecular Biology, Vol. 300. Vo-Dinh, T., Ed.: 191-223. Humana Press Inc. Totowa, NJ, USA.
97. Li, J. & R.J. Andrews. 2007. Trimodal nanoelectrode array for precise deep brain stimulation: prospects of a new technology based on carbon nanofiber arrays. Operative Neuromod. 97: 537-545.
98. Nguyen-Vu, T.D.B., H. Chen, A.M. Cassell, et al. 2006. Vertically aligned carbon nanofiber arrays; an advance toward electrical-neural interfaces. Small 2: 89-94.
99. Lovat, V., D. Pantarotto, L. Lagostena, et al. 2005. Carbon nanotubes substrates boost neuronal electrical signaling. Nano Lett. 5: 1107-1110.
100. Pereira, E.A.C. & T.R. Aziz. 2006. Surgical insights into Parkinson's disease. J. Royal Soc. Med. 99: 238-244.